Immuno Oncology

Immuno oncology is the fake incitement of the invulnerable framework to treat malignant growth, enhancing the resistant framework's normal capacity to battle the illness.It is an utilization of the crucial research of disease immunology and a developing subspeciality of oncology. It abuses the way that malignant growth cells regularly have tumor antigens, atoms on their surface that can be identified by the immunizer proteins of the insusceptible framework, official to them. The tumor antigens are often proteins or other macromolecules.Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. In 2018, James P. Allison and Tasuku Honjo got the Nobel Prize in Physiology or Medicine for their revelation of malignancy treatment by hindrance of negative invulnerable guideline.

  • Monoclonal antibodies and tumor-agnostic therapies

Related Conference of Immuno Oncology

June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 24-25, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada

Immuno Oncology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in